Search Results - "Collnot, E."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases by Ali, H., Weigmann, B., Neurath, M.F., Collnot, E.M., Windbergs, M., Lehr, C.-M.

    Published in Journal of controlled release (10-06-2014)
    “…The purpose of this study was to investigate the therapeutic potential of budesonide loaded nanocarriers for the treatment of inflammatory bowel disease (IBD)…”
    Get full text
    Journal Article
  2. 2

    VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells by Essa, S., Denzer, N., Mahlknecht, U., Klein, R., Collnot, E.M., Tilgen, W., Reichrath, J.

    “…Malignant melanoma cells express the vitamin D receptor (VDR). However, some melanoma cell lines fail to respond to the antiproliferative effects of…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Dexamethasone-loaded nanoparticle-coated microparticles: Correlation between in vitro drug release and drug transport across Caco-2 cell monolayers by Beck, R.C.R., Pohlmann, A.R., Hoffmeister, C., Gallas, M.R., Collnot, E., Schaefer, U.F., Guterres, S.S., Lehr, C.M.

    “…This work reports the preparation of dexamethasone in nanoparticle-coated microparticles and the study of the influence of such microencapsulation on drug…”
    Get full text
    Journal Article
  4. 4

    Challenge and promise: the role of miRNA for pathogenesis and progression of malignant melanoma by Essa, Salma, Denzer, N, Mahlknecht, U, Klein, R, Collnot, E M, Reichrath, J

    Published in Clinical epigenetics (01-09-2010)
    “…microRNAs are endogenous noncoding RNAs that are implicated in gene regulation. More recently, miRNAs have been shown to play a pivotal role in multiple…”
    Get full text
    Journal Article
  5. 5

    Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa by Collnot, Eva-Maria, Ali, Hussain, Lehr, Claus-Michael

    Published in Journal of controlled release (20-07-2012)
    “…Conventional treatment of inflammatory bowel disease (IBD) is based on the daily administration of high doses of immune-suppressant or anti-inflammatory drugs,…”
    Get full text
    Journal Article
  6. 6

    Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers by Collnot, Eva-Maria, Baldes, Christiane, Wempe, Michael F., Hyatt, John, Navarro, Lisa, Edgar, Kevin J., Schaefer, Ulrich Friedrich, Lehr, Claus-Michael

    Published in Journal of controlled release (10-03-2006)
    “…d-alpha-tocopheryl poly(ethylene glycol) 1000 succinate (TPGS 1000) is a widely used form of vitamin E. TPGS 1000 is comprised of a hydrophilic polar…”
    Get full text
    Journal Article
  7. 7

    Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o by Ehrhardt, Carsten, Collnot, Eva-Maria, Baldes, Christiane, Becker, Ulrich, Laue, Michael, Kim, Kwang-Jin, Lehr, Claus-Michael

    Published in Cell and tissue research (01-03-2006)
    “…The CFBE41o- cell line was generated by transformation of cystic fibrosis (CF) tracheo-bronchial cells with SV40 and has been reported to be homozygous for the…”
    Get full text
    Journal Article